CN104435329A - 一种治疗跟骨高压症的中药组合物 - Google Patents
一种治疗跟骨高压症的中药组合物 Download PDFInfo
- Publication number
- CN104435329A CN104435329A CN201410807539.8A CN201410807539A CN104435329A CN 104435329 A CN104435329 A CN 104435329A CN 201410807539 A CN201410807539 A CN 201410807539A CN 104435329 A CN104435329 A CN 104435329A
- Authority
- CN
- China
- Prior art keywords
- parts
- calcaneus
- radix
- grams
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000459 calcaneus Anatomy 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 208000024891 symptom Diseases 0.000 title abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 53
- 238000011282 treatment Methods 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000283956 Manis Species 0.000 claims description 15
- 241000131808 Scolopendra Species 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000000007 visual effect Effects 0.000 abstract description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000068689 Pimpinella saxifraga Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 23
- 210000003734 kidney Anatomy 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- IBMCQJYLPXUOKM-UHFFFAOYSA-N 1,2,2,6,6-pentamethyl-3h-pyridine Chemical compound CN1C(C)(C)CC=CC1(C)C IBMCQJYLPXUOKM-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001324 Adrenal atrophy Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000000474 heel Anatomy 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000036581 peripheral resistance Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗跟骨高压症的中药组合物,所述中药组合物由以下原料药制成:制川乌、羊红膻、生地黄、玄参、女贞子、鸡血藤、泽兰、刘寄奴、大血藤、独活、穿山甲、蜈蚣。本发明提供的治疗跟骨高压症的中药组合物,填补了目前无治疗跟骨高压症专用中药的空白,治疗效果明显,是治疗跟骨高压症的专用药物。采用本发明提供的治疗跟骨高压症的中药组合物水煎剂治疗30例患者,患者VAS评分治疗前6.72±1.77,经10~15天治疗,患者VAS评分2.32±1.17,差异有统计学意义(P<0.01)。
Description
技术领域
本发明涉及中药科技领域,特别涉及一种治疗跟骨高压症的中药组合物。
背景技术
跟骨高压症多发于中老年人,过去笼统归属于跟痛症范畴内,因诊断技术的进步,逐渐成为独立的疾病。现代医学认为,跟骨主要由松质骨构成,髓腔内静脉窦很大,且跟骨位于身体最低处,受重力影响,动脉血易于注入,而静脉血回流相对困难。在正常情况下,跟骨内注入和流出的血是平衡的,所以跟骨内压力也是衡定的。若跟骨的血运受到影响,打破了这种平衡,无论是注入还是回流障碍,造成了骨内瘀血或充血,均会导致跟骨疼痛症状。一旦诊断成立,西医多推荐行跟骨减压术,患者不易接受,故退而求其次采用物理因子治疗等,疗效并不满意。中医药治疗跟骨高压症偶见于医学刊物,但缺乏高质量文献。近年来中医界对“瘀血证”和“活血化瘀”疗法进行了大量基础及临床研究,借鉴现有成果,填补无治疗跟骨高压症专用药物的空白,具有重要临床意义。
发明内容
本发明的目的在于克服现有技术中没有针对跟骨高压症的配伍合理的中药组合物的不足而提出来的,即提供一种治疗跟骨高压症的中药组合物。
为了实现上述发明目的,本发明提供了以下技术方案:
一种治疗跟骨高压症的中药组合物,由以下质量比例的原料药制成的药剂:
制川乌2~4份、羊红膻9~15份、生地黄10~20份、玄参9~15份、女贞子6~12份、鸡血藤20~40份、泽兰8~12份、刘寄奴8~12份、大血藤10~20份、独活3~9份、穿山甲1~2份、蜈蚣1~2份。
制川乌:辛、苦、热、有大毒,归心、肝、肾、脾经。袪风湿,温经止痛。川乌有明显的抗炎、镇痛作用,局部麻醉,强心作用;还可显著降低正常血糖,对胃癌细胞有抑制作用。
羊红膻:辛、甘、温,归心、肾、肺、脾经。温肾助阳,活血化瘀,养心安神,温肺散寒。羊红膻能增强心肌及脑组织呼吸酶的活性;有明显的降压作用,并具有一定强壮作用。
生地黄:甘、苦、寒,归心、肝、肾经。清热凉血,养阴生津。生地黄有降压、镇静、抗炎、抗过敏、强心、利尿作用;有缩短凝血时间的作用;地黄有对抗连续服用地塞米松后血浆皮质酮浓度的下降,并能防止肾上腺皮质萎缩的作用,具有促进机体淋巴母细胞的转化、增加T淋巴细胞数量的作用,并能增强网状内皮细胞的吞噬功能,特别对免疫功能低下者作用更明显。
玄参:甘、苦、咸、微寒,归肺、胃、肾经。清热凉血,泻火解毒,滋阴。玄参有降血压、增加心肌血流量、抑菌、抗炎、镇静、抗惊厥作用。
女贞子:甘、苦、凉,归肝、肾经。滋补肝肾,乌须明目。女贞子可增强非特异性免疫功能,对异常的免疫功能具有双向调节作用;对化疗和放疗所致的白细胞减少有升高作用;可降低血清胆固醇,有预防和消减动脉粥样硬化斑块和减轻斑块厚度的作用,能减少冠状动脉粥样硬化病变数并减轻其阻塞程度;有强心、利尿、降血糖、保肝及抗衰老作用;并有止咳、缓泻、抗菌、抗肿瘤作用。
鸡血藤:苦、微甘、温,归肝、肾经。行血补血,调经,舒筋活络。鸡血藤能增加股动脉血流量,降低血管阻力,对血小板聚集有明显抑制作用;可降低胆固醇,明显对抗动脉粥样硬化病变;还有抗炎、镇静、催眠作用,并对免疫系统有双向调节功能。
泽兰:苦、辛、微温,归肝、脾经。活血调经,祛瘀消痈,利水消肿。泽兰能对抗体外血栓形成,有轻度抑制凝血系统与增强纤溶活性的作用;还有强心作用。
刘寄奴:苦、温,归心、肝、脾经。散瘀止痛,疗伤止血,破血通经,消食化积。刘寄奴可加速血液循环,解除平滑肌痉挛,促进血凝作用;还有明显的抗缺氧,抑菌作用。
大血藤:苦、平,归大肠、肝经。清热解毒,活血,祛风,止痛。大血藤有较强的抑菌作用,能增加冠脉流量,抑制血栓形成。
独活:辛、苦、微温,归肾、膀胱经。袪风湿,止痛,解表。独活有抗炎、镇痛及镇静作用;对血小板聚集有抑制作用;并有降压作用、抗肿瘤作用。
穿山甲:咸、微寒,归肝、胃经。活血消癥,通经,下乳,消肿排脓。穿山甲能延长凝血时间,降低血液粘度;有直接扩张血管壁降低外周阻力,显著增加股动脉血流量的作用;还具有抗炎、抗心肌缺氧、升高白细胞的作用。
蜈蚣:辛、温、有毒,归肝经。息风镇痉,攻毒散结,通络止痛。蜈蚣能改善微循环,延长凝血时间,降低血粘度;并有明显的抗惊厥、镇痛、抗炎作用。
跟骨高压症典型症状为休息痛,符合中医学“瘀血证”的特点,且中医学认为“肾主骨”, 肾健则骨强,中年人肾气渐衰,脉道之血鼓动无力,易于瘀阻于局部而发为本病。故治疗上当用补肾益精和活血化瘀之法。采用制川乌、羊红膻温肾助阳,活血化瘀;生地黄、玄参、女贞子滋补精血;鸡血藤、泽兰、刘寄奴、大血藤行气活血;独活袪风止痛,引药下行;穿山甲、蜈蚣活血散结。诸药合用,攻补兼施,标本兼治,补不留瘀,攻不伤正。
优选的,所述治疗跟骨高压症的中药组合物由以下质量比例的原料药制成的药剂:
制川乌2~4份、羊红膻11~13份、生地黄13~17份、玄参11~13份、女贞子8~10份、鸡血藤25~35份、泽兰9~11份、刘寄奴9~11份、大血藤13~17份、独活5~7份、穿山甲1~2份、蜈蚣1~2份。
进一步优选的,所述治疗跟骨高压症的中药组合物由以下质量比例的原料药制成的药剂:
制川乌3份、羊红膻12份、生地黄15份、玄参12份、女贞子9份、鸡血藤30份、泽兰10份、刘寄奴10份、大血藤15份、独活6份、穿山甲1.5份、蜈蚣1.5份。
所述治疗跟骨高压症的中药组合物可以采用现有中药制剂技术制备成任何常规内服制剂,例如可以将上述组分采用水煎得到水煎剂,还可以通过其它现有中药制剂技术将所述治疗跟骨高压症的中药组合物制备成片剂、水蜜丸、胶囊剂、散剂、膏剂、口服液、颗粒剂。
与现有技术相比,本发明的有益效果
本发明提供的治疗跟骨高压症的中药组合物,填补无治疗跟骨高压症专用药物的空白,治疗效果明显,是治疗跟骨高压症的专用药物。
一种治疗跟骨高压症的中药组合物,临床疗效总结
1 一般资料
30例患者中,男18例,女12例;年龄最大71岁, 最小42岁, 平均52.1 ±3.7岁;病程最长12年,最短7天,平均2.1年;单侧足跟痛24 例;双侧足跟痛6 例。
2 诊断标准
参照文献[Xuzhenhua . Peoistent painful heel and intrataleaneal pressure.JA cad An bul foot surg(AM),1984 , (2) : 26.]标准,将具有静息痛且跟骨内压力> 2.67kPa 称为跟骨高压症。
3 治疗方法
制川乌3克、羊红膻12克、生地黄15克、玄参12克、女贞子9克、鸡血藤30克、泽兰10克、刘寄奴10克、大血藤15克、独活6克、穿山甲(研末冲服)1.5克、蜈蚣(研末冲服)1.5克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
4 治疗结果
4.1 疗效标准:采用目测类比评分法(visual analoguescale,
VAS)(蒋协远,王大伟主编.2010年最新骨科临床疗效评价标准.[M]
北京:人民卫生出版社,2010,123-124)评定两组患者治疗前后疼
痛程度,其中0分为无痛,10分为最痛,分值越高,疼痛越剧烈。
4.2 结果:患者VAS评分治疗前6.72±1.77,经10~15天治疗,患者VAS评分为2.32±1.17,差异有统计学意义(P<0.01)。
具体实施方式
下面结合具体实施方式对本发明作进一步的详细描述。但不应将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明内容所实现的技术均属于本发明的范围。
实施例1
一种治疗跟骨高压症的中药组合物,是由制川乌4克、羊红膻15克、生地黄20克、玄参15克、女贞子12克、鸡血藤40克、泽兰12克、刘寄奴12克、大血藤20克、独活9克、穿山甲(研末冲服)2克、蜈蚣(研末冲服)2克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
实施例2
一种治疗跟骨高压症的中药组合物,是由制川乌4克、羊红膻13克、生地黄17克、玄参13克、女贞子10克、鸡血藤35克、泽兰11克、刘寄奴11克、大血藤17克、独活7克、穿山甲(研末冲服)2克、蜈蚣(研末冲服)2克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
实施例3
一种治疗跟骨高压症的中药组合物,是由制川乌3克、羊红膻12克、生地黄15克、玄参12克、女贞子9克、鸡血藤30克、泽兰10克、刘寄奴10克、大血藤15克、独活6克、穿山甲(研末冲服)1.5克、蜈蚣(研末冲服)1.5克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
实施例4
一种治疗跟骨高压症的中药组合物,是由制川乌2克、羊红膻11克、生地黄13克、玄参11克、女贞子8克、鸡血藤25克、泽兰9克、刘寄奴9克、大血藤13克、独活5克、穿山甲(研末冲服)1克、蜈蚣(研末冲服)1克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
实施例5
一种治疗跟骨高压症的中药组合物,是由制川乌2克、羊红膻9克、生地黄10克、玄参9克、女贞子6克、鸡血藤20克、泽兰8克、刘寄奴8克、大血藤10克、独活3克、穿山甲(研末冲服)1克、蜈蚣(研末冲服)1克,按照常规中药制剂技术制成水煎剂,每人每日一剂。
Claims (4)
1.一种治疗跟骨高压症的中药组合物,其特征在于由以下质量比例的原料药制成的药剂:
制川乌2~4份、羊红膻9~15份、生地黄10~20份、玄参9~15份、女贞子6~12份、鸡血藤20~40份、泽兰8~12份、刘寄奴8~12份、大血藤10~20份、独活3~9份、穿山甲1~2份、蜈蚣1~2份。
2.如权利要求1所述的治疗跟骨高压症的中药组合物,其特征在于由以下质量比例的原料药制成的药剂:
制川乌2~4份、羊红膻11~13份、生地黄13~17份、玄参11~13份、女贞子8~10份、鸡血藤25~35份、泽兰9~11份、刘寄奴9~11份、大血藤13~17份、独活5~7份、穿山甲1~2份、蜈蚣1~2份。
3. 如权利要求1所述的治疗跟骨高压症的中药组合物,其特征在于由以下质量比例的原料药制成的药剂:
制川乌3份、羊红膻12份、生地黄15份、玄参12份、女贞子9份、鸡血藤30份、泽兰10份、刘寄奴10份、大血藤15份、独活6份、穿山甲1.5份、蜈蚣1.5份。
4.如权利要求1所述治疗跟骨高压症的中药组合物的制备方法,其特征在于将所述质量比例的中药组分制备成水煎剂、片剂、水蜜丸、胶囊剂、散剂、膏剂、口服液、颗粒剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410807539.8A CN104435329A (zh) | 2014-12-23 | 2014-12-23 | 一种治疗跟骨高压症的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410807539.8A CN104435329A (zh) | 2014-12-23 | 2014-12-23 | 一种治疗跟骨高压症的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435329A true CN104435329A (zh) | 2015-03-25 |
Family
ID=52882590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410807539.8A Pending CN104435329A (zh) | 2014-12-23 | 2014-12-23 | 一种治疗跟骨高压症的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435329A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758492A (zh) * | 2015-04-28 | 2015-07-08 | 何欣 | 一种治疗跟骨高压症的中药组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258670A (zh) * | 2011-07-14 | 2011-11-30 | 冯素英 | 一种治疗跟痛症的药物 |
CN103751758A (zh) * | 2014-02-13 | 2014-04-30 | 杨延庆 | 一种治疗足跟痛的药物及其制备方法 |
CN103989768A (zh) * | 2014-05-05 | 2014-08-20 | 赵霞 | 治疗跟痛症的泡脚方剂及外敷药物 |
CN104095948A (zh) * | 2013-04-07 | 2014-10-15 | 陈洪波 | 一种治疗足跟痛的外用浴剂 |
-
2014
- 2014-12-23 CN CN201410807539.8A patent/CN104435329A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258670A (zh) * | 2011-07-14 | 2011-11-30 | 冯素英 | 一种治疗跟痛症的药物 |
CN104095948A (zh) * | 2013-04-07 | 2014-10-15 | 陈洪波 | 一种治疗足跟痛的外用浴剂 |
CN103751758A (zh) * | 2014-02-13 | 2014-04-30 | 杨延庆 | 一种治疗足跟痛的药物及其制备方法 |
CN103989768A (zh) * | 2014-05-05 | 2014-08-20 | 赵霞 | 治疗跟痛症的泡脚方剂及外敷药物 |
Non-Patent Citations (1)
Title |
---|
曹伟志: "补肾化瘀汤治疗跟骨高压症30例", 《湖南中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758492A (zh) * | 2015-04-28 | 2015-07-08 | 何欣 | 一种治疗跟骨高压症的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (zh) | 一种治疗骨伤的中药组合物 | |
CN101766773B (zh) | 一种治疗足跟痛病的中药 | |
CN102512630B (zh) | 一种治疗胆囊结石的中药组合物 | |
CN109966413A (zh) | 一种用于治疗化疗药物所致的周围神经病变的中药外用制剂 | |
CN101396541B (zh) | 一种治疗颈椎病的中药 | |
CN101313886A (zh) | 一种浴足保健中药水 | |
CN105311420A (zh) | 一种治疗中风及后遗症的中药组合物 | |
CN103599438B (zh) | 一种治疗骨病的中药酊及其制备方法 | |
CN104435329A (zh) | 一种治疗跟骨高压症的中药组合物 | |
CN106362066A (zh) | 一种治疗风湿类风湿性疾病的药酒及其制备方法 | |
CN102406870A (zh) | 一种治疗风湿痹痛的药物 | |
CN101195002B (zh) | 祛痛保健中药贴膏 | |
CN104606511A (zh) | 一种预防微创治疗腰椎间盘突出症术后反跳现象的中药 | |
CN104491324A (zh) | 一种患者术后用活血通络气雾剂 | |
CN103285108B (zh) | 一种治疗腰痛的中药组合物 | |
CN106074784A (zh) | 治疗冠心病心肌缺血的中药 | |
CN105999126A (zh) | 一种治疗颈椎病的中药组合物 | |
CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
CN104784420A (zh) | 一种防治血液透析慢性持续性低血压的中药组合物 | |
CN104740193A (zh) | 一种治疗颈肩肌肉劳损综合症的中药组合物及其制备方法 | |
CN103768573B (zh) | 一种治疗脾胃虚寒型眼流泪瘙痒症的中药组合物 | |
CN101455752A (zh) | 一种治疗跌打损伤的中草药药方 | |
CN104352858B (zh) | 一种治疗小儿腹泻的中药组合物 | |
CN103800621A (zh) | 一种治疗前列腺肥大以及前列腺炎的中药组合物 | |
CN101310755A (zh) | 一种促进骨折快速痊愈的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
RJ01 | Rejection of invention patent application after publication |